Join the Breast Cancer, Metastatic group to help and get support from people like you.
Breast Cancer, Metastatic News (Page 3)
Related terms: Metastatic Breast Cancer
SABCS: Risk-Reducing Surgery Improves Outcomes in Young Breast Cancer Patients With BRCA Mutations
MONDAY, Dec. 16, 2024 – Risk-reducing mastectomy (RRM) and salpingo-oophorectomy (RRSO) are both associated with significant improvements in outcomes among young BRCA carriers with breast cancer,...
SABCS: Chest Wall Irradiation Does Not Impact Survival in Breast Cancer
MONDAY, Dec. 16, 2024 – For patients with intermediate-risk breast cancer, chest wall irradiation (CWI) after mastectomy does not influence 10-year overall survival, according to a study presented...
2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence
THURSDAY, Dec. 12, 2024 – During 2004 to 2021, there was an increase in distant-stage breast cancer incidence rates at presentation, according to a study published online Dec. 10 in Radiology. R....
Adding Previous Screening Mammogram Images Improves Cancer Prediction
MONDAY, Dec. 9, 2024 – Five-year breast cancer (BC) risk prediction is improved with the addition of previous screening mammogram images beyond static models, according to a study published online...
Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer
THURSDAY, Oct. 31, 2024 – Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated,...
Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
WEDNESDAY, Oct. 30, 2024 – A lack of health insurance coverage raises the risk that cancers among Black and Hispanic Americans will be caught too late, a new study suggests. Being uninsured accounts...
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
WEDNESDAY, Oct. 30, 2024 – For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, according to a study published online Oct. 23 in...
Medicaid Expansion Increases Guideline-Concordant Treatment for Breast Cancer
FRIDAY, Oct. 25, 2024 – Expanding Medicaid is associated with an increase in receipt of guideline-concordant treatment among nonelderly women newly diagnosed with hormone receptor (HR)-negative,...
Aerobic Exercise May Ease 'Brain Fog' of Breast Cancer Chemo
WEDNESDAY, Oct. 23, 2024 – Women fighting breast cancer can relieve some of their chemotherapy “brain fog” through aerobic exercise, a new clinical trial in Canada suggests. Breast cancer patients on...
Excess Adiposity Plays Role in Postmenopausal HR-Positive Breast Cancer
THURSDAY, Oct. 17, 2024 – Excess body fat plays a role in postmenopausal hormone receptor-positive breast cancer, which could be underestimated using only body mass index (BMI), according to a study...
FDA Approves Itovebi for Locally Advanced, Metastatic Breast Cancer
WEDNESDAY, Oct. 16, 2024 – The U.S. Food and Drug Administration approved Itovebi (inavolisib), in combination with palbociclib (Ibrance) and fulvestrant, for the treatment of adults with...
New Hope Against Breast Cancers That Spread to the Brain
TUESDAY, Oct. 8, 2024 – A recently approved targeted chemotherapy drug can significantly extend the lives of advanced breast cancer patients who have developed tumors in their brains, new clinical...
Breast Cancer Treatments Might Speed Aging, Study Finds
TUESDAY, Oct. 8, 2024 – Any form of breast cancer treatment appears to speed the aging of the recipient's cells, a new study finds. “For the first time, we're showing that the [aging] signals we o...
AI May Identify Women at Risk for Future Breast Cancer
TUESDAY, Oct. 8, 2024 – Artificial intelligence (AI) scores may be able to estimate the risk for future breast cancer and lead to earlier diagnosis, according to a study published online Oct. 3...
U.S. Breast Cancer Deaths Keep Declining, Though Disparities Remain
TUESDAY, Oct. 1, 2024 – While women overall are less likely to die of breast cancer now, some alarming disparities remain, a new American Cancer Society (ACS) analysis warns. Death rates for...
Further information
Related condition support groups
Related drug support groups
anastrozole, letrozole, Herceptin, Arimidex, Femara, trastuzumab, tamoxifen, Ibrance